Finance

Lists
002038:SHE
Beijing SL Pharmaceutical Co Ltd
CNÂ¥5.15
+1.18%
(+0.060) 1D
Nov 4, 3:05:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002038...
Open
CNÂ¥5.09
High
CNÂ¥5.16
Low
CNÂ¥5.04
Mkt. cap
5.23B
Avg. vol.
17.35M
Volume
14.39M
Dividend
0.19%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 22, 2026
52-wk high
CNÂ¥9.40
52-wk low
CNÂ¥4.81
EPS
-CNÂ¥0.82
Shares outstanding
1.03B
No. of employees
901
Open
CNÂ¥5.09
High
CNÂ¥5.16
Low
CNÂ¥5.04
Mkt. cap
5.23B
Avg. vol.
17.35M
Volume
14.39M
Dividend
0.19%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 22, 2026
52-wk high
CNÂ¥9.40
52-wk low
CNÂ¥4.81
EPS
-CNÂ¥0.82
Shares outstanding
1.03B
No. of employees
901
News stories
From web sources and news partners
About Beijing SL Pharmaceutical Co Ltd
CEO-
Employees901
FoundedDec 24, 1994
Headquarters-
SectorBiotechnology
Industry-
Websiteslpharm.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
164.89M
136.84M
114.64M
139.27M
Cost of goods sold
60.70M
49.79M
48.90M
66.80M
Cost of revenue
60.70M
49.79M
48.90M
66.80M
Research and development expenses
40.29M
7.87M
29.45M
18.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.75M
43.79M
64.82M
41.37M
Operating expense
129.81M
50.41M
100.99M
57.73M
Total operating expenses
190.51M
100.20M
149.90M
124.53M
Operating income
-25.61M
36.64M
-35.26M
14.74M
Other non operating income
-617.38M
-475.43K
447.02K
2.64M
EBT including unusual items
-437.00M
-103.79M
-193.68M
-115.47M
EBT excluding unusual items
-640.58M
36.96M
-27.63M
24.22M
Income tax expense
51.84M
-16.52M
-25.15M
-20.03M
Effective tax rate
-11.86%
15.92%
12.98%
17.35%
Other operating expenses
2.71M
-1.03M
3.25M
1.19M
Net income
-488.30M
-86.11M
-168.96M
-95.05M
Net profit margin
-296.13%
-62.93%
-147.39%
-68.25%
Earnings per share
-
-
-
-
Interest and investment income
2.22M
795.24K
8.21M
5.80M
Interest expense
-
-
-
-
Net interest expenses
2.22M
795.24K
8.21M
5.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
16.08M
78.33M
6.42M
56.43M
Gain or loss from assets sale
46.02K
-
5.85K
-5.85K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps